Vanessa C. Abilio

Ribeirao Preto, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Prophylactic efficacy of cannabidiol and sodium nitroprusside in a ketamine model of schizophrenia: sex-dependent effects on positive-like and cognitive impairments.

Prophylactic efficacy of cannabidiol and sodium nitroprusside in a ketamine model of schizophrenia: sex-dependent effects on positive-like and cognitive impairments.

Journal: Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)

Published: April 30, 2025

Preventive beneficial effects of cannabidiol in a reserpine-induced progressive model of parkinsonism.

Preventive beneficial effects of cannabidiol in a reserpine-induced progressive model of parkinsonism.

Journal: Frontiers in pharmacology

Published: December 04, 2024

Cannabidiol induces autophagy via CB1 receptor and reduces α-synuclein cytosolic levels.

Cannabidiol induces autophagy via CB1 receptor and reduces α-synuclein cytosolic levels.

Journal: Brain research

Published: July 02, 2024

Cannabidiol-Induced Autophagy Ameliorates Tau Protein Clearance.

Cannabidiol-Induced Autophagy Ameliorates Tau Protein Clearance.

Journal: Neurotoxicity research

Published: February 06, 2024

Cannabidiol Recovers Dopaminergic Neuronal Damage Induced by Reserpine or α-synuclein in Caenorhabditis elegans.

Cannabidiol Recovers Dopaminergic Neuronal Damage Induced by Reserpine or α-synuclein in Caenorhabditis elegans.

Journal: Neurochemical research

Published: September 05, 2022

Harmine impairs memory performance of treated rats and nontreated cagemates.

Harmine impairs memory performance of treated rats and nontreated cagemates.

Journal: Experimental and clinical psychopharmacology

Published: November 04, 2021

Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?

Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?

Journal: Frontiers in pharmacology

Published: November 30, 2020

Changes in the mesocorticolimbic pathway after low dose reserpine-treatment in Wistar and Spontaneously Hypertensive Rats (SHR): Implications for cognitive deficits in a progressive animal model for Parkinson's disease.

Changes in the mesocorticolimbic pathway after low dose reserpine-treatment in Wistar and Spontaneously Hypertensive Rats (SHR): Implications for cognitive deficits in a progressive animal model for Parkinson's disease.

Journal: Behavioural brain research

Published: November 12, 2020

Cannabidiol induces autophagy via ERK1/2 activation in neural cells.

Cannabidiol induces autophagy via ERK1/2 activation in neural cells.

Journal: Scientific reports

Published: June 24, 2020

Thimet Oligopeptidase (EC 3.4.24.15) Key Functions Suggested by Knockout Mice Phenotype Characterization.

Thimet Oligopeptidase (EC 3.4.24.15) Key Functions Suggested by Knockout Mice Phenotype Characterization.

Journal: Biomolecules

Published: July 03, 2019

Response to the comment on "an animal model of what? the case of spontaneously hypertensive rats".

Response to the comment on "an animal model of what? the case of spontaneously hypertensive rats".

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: April 03, 2019

Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit.

Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit.

Journal: Neuropharmacology

Published: October 17, 2018

Showing 1-12 of 38

Last Updated: 09/26/2026